Ban on Contracting with Risky Biotechnology Companies for U.S. Security.
This act prohibits U.S. government agencies and their contractors from using biotechnology equipment or services from companies deemed a national security concern. The goal is to safeguard citizens' data and national interests from foreign adversary influence. While primarily affecting government procurement, citizens might experience indirect impacts on government-funded healthcare services, with critical exceptions in place.
Key points
U.S. government agencies and contractors are barred from procuring or using biotech equipment/services from "companies of concern."
The law aims to protect national security and citizens' multiomic data from foreign adversaries.
Exceptions include intelligence activities, overseas healthcare for U.S. personnel, and public health emergencies.
The government will identify and list these "companies of concern," with a process for review and appeal.
Introduced
Additional Information
Print number: 119_S_3469
Sponsor: Sen. Peters, Gary C. [D-MI]
Process start date: 2025-12-11